COGorg Profile Banner
Children’s Oncology Group Profile
Children’s Oncology Group

@COGorg

Followers
4K
Following
894
Media
58
Statuses
371

The Children’s Oncology Group (COG) is the world’s largest organization devoted exclusively to childhood and adolescent cancer research.

Joined May 2018
Don't wanna be here? Send us removal request.
@COGorg
Children’s Oncology Group
8 days
In honor of #COG’s 25th year, we are aiming to raise $25k for our largest philanthropic supporter, @StBaldricks, by putting a NOLA twist on fundraising. Take a look at these Mardi Paws superstars and support your favorite pet by “voting” w/ your donation!
1
1
3
@COGorg
Children’s Oncology Group
1 month
The #COG has endorsed a #clinical practice guideline on Food Restrictions to Prevent Infections in June of 2025. This was developed by @POGO4kids.
0
0
2
@grok
Grok
8 days
What do you want to know?.
477
365
2K
@COGorg
Children’s Oncology Group
2 months
The #COGF Newsletter - Summer 2025 is here! This edition covers liquid biopsies, coordinating clinical trials, B+ Foundation philanthropic support, & an interview w/ AYA Chair, Mike Roth.
0
1
4
@COGorg
Children’s Oncology Group
3 months
#COG celebrates Clinical Trials Day!
Tweet media one
0
2
4
@COGorg
Children’s Oncology Group
3 months
RFP - Provision of professional consulting services in brand strategy for COG - Proposal due July 4, 2025. To see more details:.
0
0
2
@COGorg
Children’s Oncology Group
4 months
The #COG has endorsed a #clinical practice guideline on Less Restrictions in Daily Life in March 2025. This was developed by the Dutch Children's Oncology Group. #DCOG
0
1
2
@COGorg
Children’s Oncology Group
5 months
The #COGF Newsletter - Spring 2025 is here! This edition covers the road from idea to clinical trial, a foundations philanthropic support for kidney cancer research, an interview w/ Renal Chair, Nicholas Cost, & a letter from our Group Chair, Doug Hawkins.
0
2
4
@COGorg
Children’s Oncology Group
6 months
RT @NSABPFoundation: Please take a moment to read this incredibly important statement from our partners at @NRGOnc and all of the NCTN Grou….
0
1
0
@COGorg
Children’s Oncology Group
6 months
RT @eaonc: The NCTN Cooperative Group Chairs are concerned about the impact of the proposed changes in the @NIH & @theNCI budgets; their su….
Tweet card summary image
ecog-acrin.org
0
14
0
@COGorg
Children’s Oncology Group
8 months
RT @CHOPCancerCntr: In this Q&A w/ @COGorg, Dr. David Teachey, who is also the #COG ALL Chair, discusses his career as well as the breakthr….
0
1
0
@COGorg
Children’s Oncology Group
8 months
The #COGF Newsletter - Winter 2024 is here! This edition covers #AALL1731, interviews on the importance of regional hospitals, Fourth and Goal's philanthropic support, Ewing Sarcoma Survivor story, & an interview with #COG ALL chair, Dr. David Teachey,
0
0
4
@COGorg
Children’s Oncology Group
9 months
Over 15 #COG authors presented at @ASH_hematology #ASH24 this weekend, including #AALL1731 study co-chairs Drs. Rau and Gupta at the plenary session! Congratulations to all the authors on their presentations!
Tweet media one
Tweet media two
2
2
18
@COGorg
Children’s Oncology Group
9 months
We congratulate the #COG institutions who took part in #AALL1731, as well as @Amgen, the maker of BLINCYTO®. A special congratulations to Drs. @RachelRau3 & Gupta, for co-chairing this transformative study. Lastly, thank you to all of the patients & families who participated.
0
2
8
@COGorg
Children’s Oncology Group
9 months
#ALL1731 results demonstrate 3-year disease-free survival rate of 96% for patients treated with blinatumomab & set a new treatment standard for most children with newly diagnosed B-ALL.
2
1
4
@COGorg
Children’s Oncology Group
9 months
#COG is proud to announce the #AALL1731 findings. During the plenary session at @ASH_hematology #ASH24, Drs. Rachel Rau and Sumit Gupta, co-chairs of AALL1731, presented the results that are now published in the @NEJM.
Tweet card summary image
nejm.org
B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among chi...
1
6
16
@COGorg
Children’s Oncology Group
9 months
RT @NEJM: Presented at #ASH24: . The addition of blinatumomab after induction chemotherapy in children with standard-risk disease of avera….
0
17
0
@COGorg
Children’s Oncology Group
9 months
RT @NEJM: Original Article: Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children (AALL1731) .
0
22
0
@COGorg
Children’s Oncology Group
9 months
RT @ASHClinicalNews: Compared with #chemotherapy alone, the addition of #blinatumomab to standard intensity chemotherapy resulted in signif….
0
4
0
@COGorg
Children’s Oncology Group
9 months
RT @POGO4kids: Exciting news from @COGorg presented at #ASH24 showing incredible results by adding #blinatumomab to standard therapy in ped….
0
6
0
@COGorg
Children’s Oncology Group
9 months
RT @Amgen: B-ALL NEWS: Today, Amgen announced that @COGorg will present study results for pediatric patients with B-cell precursor acute ly….
0
8
0